When RevMan is the right answer
RevMan is Cochrane's own tool, and Cochrane reviews have to be written in it. It is free, the statistics are trusted, and if you are authoring a Cochrane review there is no decision to make. This page is for everyone else: the researcher writing a non-Cochrane systematic review who finds RevMan's workflow built around a process they are not part of.
What people look for in an alternative
The complaints that send people searching are consistent: data entry requires setting up comparisons and outcomes before you can type a number, the steps before analysis (searching, screening, extraction) live in other tools, and there is no network meta-analysis. GRADE means switching to GRADEpro, and the PRISMA diagram means yet another tool.
How Covexe compares
- Abstract and full-text screening with a second blinded reviewer and Cohen's kappa: built in. RevMan starts after screening.
- Data extraction: AI-assisted, from your PDFs, into templates you define.
- Meta-analysis: fixed and random effects, subgroups, meta-regression, leave-one-out, funnel plots with Egger's and Begg's tests, validated against R's metafor.
- Network meta-analysis: included, validated against R's netmeta. RevMan does not do NMA.
- GRADE and the PRISMA 2020 flow diagram: in the same project, no extra tools.
- Price: free core tools, in the browser, no install.
Moving between them
Covexe exports your reference set as RIS, which RevMan, EndNote, and Zotero all read, and your data and results as CSV or Excel. Trying Covexe does not lock you in.